Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid, UMDNJ Get $7.5M Grant to Further Develop GeneXpert

NEW YORK (GenomeWeb News) – Cepheid today said that the National Institute of Allergy and Infectious Diseases has awarded a grant of $7.5 million to the firm and the University of Medicine and Dentistry of New Jersey to further develop the GeneXpert System.

Specifically, the grant is being used to support the development of a new 10-color detection technology for Cepheid's GeneXpert System, which currently is capable of six-color detection. Cepheid said that when coupled with its virtual array technology, the 10-color system will potentially be able to simultaneously detect up to 100 different targets per sample.

The 10-color technology is expected to deliver more cost-effective infectious disease panel testing and enable the development of new, comprehensive antimicrobial resistance and oncology tests, said Cepheid. The Sunnyvale, Calif.-based firm expects to establish clinical utility of the new system through development of a new assay for multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis, with additional GeneXpert test to follow.

"This dramatic increase in the number of targets we can detect with a single test will enable us to develop an assay for MDR and XDR Mycobacterium tuberculosis that will give clinicians a full panel of information, including resistance to the widest variety of treatments," UMDNJ's David Alland said in a statement.

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.